Evidence map›Paper›PMID 29749650›Full record

ArticleJournal of leukocyte biology2018

IRAK4 activity controls immune responses to intracellular bacteria Listeria monocytogenes and Mycobacterium smegmatis.

Goutham Pattabiraman, Michael Murphy, Federica Agliano, Keaton Karlinsey, Andrei E Medvedev

Open access · greenAbstract read
In one paragraph

Article in Journal of leukocyte biology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
0.9field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Goutham PattabiramanDepartment of Immunology, University of Connecticut Health Center, Farmington, Connecticut, USA.
Michael MurphyDepartment of Immunology, University of Connecticut Health Center, Farmington, Connecticut, USA.
Federica AglianoDepartment of Immunology, University of Connecticut Health Center, Farmington, Connecticut, USA.
Keaton KarlinseyDepartment of Immunology, University of Connecticut Health Center, Farmington, Connecticut, USA.
Andrei E MedvedevDepartment of Immunology, University of Connecticut Health Center, Farmington, Connecticut, USA.
UConn Health · US

Funding

Effect of Bacterial Tolerance on TLR Signal TransductionR01AI059524 · NIAID · UNIVERSITY OF MARYLAND BALTIMORE · PI MEDVEDEV, ANDREI E · 2005 to 2014
$2.6M
Role of IRAK-4 in Rheumatoid ArthritisR21AI124234 · NIAID · UNIVERSITY OF CONNECTICUT SCH OF MED/DNT · PI MEDVEDEV, ANDREI E · 2015 to 2016
$439k
NIAID NIH HHS R01 AI059524NIAID NIH HHS R21 AI124234NIH HHS AI059524NIH HHS AI124234
6 · The paper itself

Abstract

IL-1 receptor-associated kinase (IRAK) 4 is a central enzyme of the TLR pathways. This study tested the hypothesis that IRAK4 kinase activity is prerequisite for regulating innate immunity during infections with intracellular bacteria. To this end, we analyzed responses of macrophages obtained from mice expressing wild-type (WT) IRAK4 or its kinase-inactive K213M mutant (IRAK4

Indexed as

Immunity, InnateAnimalsCytokinesFemaleImmunologic Deficiency SyndromesInterleukin-1 Receptor-Associated KinasesListeria monocytogenesListeriosisLiverMacrophagesMaleMiceMice, Inbred C57BLMutation, MissenseMycobacterium Infections, NontuberculousMycobacterium smegmatisCytokinesInterleukin-1 Receptor-Associated KinasesIrak4 protein, mouseNitric OxideNitric Oxide Synthase Type IINos2 protein, mouseinfectioninflammationinnate immunitymacrophageTLR

Identifiers

PMID29749650
PMCPMC6162151
OpenAlexW2800262787

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.